To assess the ability of our isoform expression signature to distinguish ER+ and TN breast cancer subtypes in this independent cohort, we used the Nanostring data from the discovery cohort to build a logistic regression-based subtype classifier and applied that classifier to the replication cohort. This evidence concerns the gene ESR1 and breast cancer.